Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Precision Diagnostics in Prostate Cancer Treatment (PREDICT): A Phase II Multiarm Biomarker-Based Study (Alliance A032102).

JCO oncology advances·2026
Same author

Matching Patients With Cell Surface-Targeted Clinical Trials Using Large Language Models.

JCO precision oncology·2026
Same author

Clinical Utility of Transcriptomic Signatures to Identify Androgen Receptor and Neuroendocrine Signaling in Prostate Cancer.

JCO precision oncology·2026
Same author

Prostate Cancer-Associated Fibroblasts: A Review on CAF Functions, Heterogeneity, Resistance Mechanisms, and Future in a Chip.

International journal of molecular sciences·2026
Same author

Multi-Institutional Study Evaluating the Role of Early Circulating Tumor DNA Dynamics During Treatment With Immune Checkpoint Inhibitors in Patients With Advanced-Stage Melanoma.

JCO precision oncology·2026
Same author

OGDHL Promotes Prostate Cancer Progression and Regulates Neuroendocrine Marker Expression and Nucleotide Abundance.

Molecular cancer research : MCR·2026

Related Experiment Video

Updated: Jun 12, 2026

Handling and Assessment of Human Primary Prostate Organoid Culture
08:45

Handling and Assessment of Human Primary Prostate Organoid Culture

Published on: January 17, 2019

Identifying and Addressing Barriers to Live Primary Prostate Cancer Cell Research in Veterans.

Alex Carlson1, Erika Heninger2, Emma E Recchia2

  • 1Department of Medicine, University of Wisconsin-Madison, Madison, Wisconsin.

Cancer Research Communications
|June 10, 2026
PubMed
Summary

No prostate cancer studies have used live cells from Veteran donors in the last decade. Veterans show high interest in participating in such research, indicating a need for more research opportunities.

More Related Videos

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
12:13

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

Related Experiment Videos

Last Updated: Jun 12, 2026

Handling and Assessment of Human Primary Prostate Organoid Culture
08:45

Handling and Assessment of Human Primary Prostate Organoid Culture

Published on: January 17, 2019

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
12:13

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

Area of Science:

  • Oncology
  • Genomics
  • Translational Research

Background:

  • Veterans exhibit unique comorbidities and exposures potentially influencing distinct tumor biology.
  • Understanding Veteran tumor genomics and transcriptomics is crucial for personalized treatment strategies.

Purpose of the Study:

  • To assess the landscape of Veteran-focused prostate cancer research utilizing live primary cells.
  • To evaluate Veteran interest and engagement in live cell biospecimen donation studies.

Main Methods:

  • Systematic literature review of prostate cancer studies (last decade) using live primary cells.
  • Analysis of Veteran enrollment and survey responses from a live cell biospecimen donation study.
  • Evaluation of an informatics-based screening strategy's efficiency.

Main Results:

  • Zero prostate cancer studies in the last decade utilized live primary cells from Veterans, compared to 105 from the general population.
  • 94% of Veterans approached for live cell donation enrolled, with 83% finding participation meaningful.
  • 70% of participating Veterans reported increased healthcare satisfaction.
  • An informatics strategy reduced participant screening time by 89%.

Conclusions:

  • A significant gap exists in Veteran-specific prostate cancer research using live primary cells, primarily due to a lack of research opportunities.
  • Veterans demonstrate strong interest and willingness to participate in live cell research.
  • Implementing efficient screening strategies can facilitate Veteran-focused translational research.